nanoMR Inc. Names Colin Dykes, Ph.D., Chief Scientific Officer
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--nanoMR, an emerging diagnostic company that develops real-time, ultrasensitive technology for detecting pathogens in biological samples, today announced the appointment of Colin W. Dykes, Ph.D., as chief scientific officer. His primary responsibility will be to establish studies that validate nanoMR’s pathogen detection system in clinical settings.